ADGC Publications

Found 23 results
Filters: Keyword is Apolipoproteins E  [Clear All Filters]
2023
Fan KH, Francis L, M Aslam M, Bedison MA, Lawrence E, Acharya V, Snitz BE, Ganguli M, DeKosky ST, Lopez OL et al..  2023.  Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease.. Neurobiol Aging. 122:107-111.
2022
Rajabli F, Beecham GW, Hendrie HC, Baiyewu O, Ogunniyi A, Gao S, Kushch NA, Lipkin-Vasquez M, Hamilton-Nelson KL, Young JI et al..  2022.  A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.. PLoS Genet. 18(7):e1009977.
Jun GR, You Y, Zhu C, Meng G, Chung J, Panitch R, Hu J, Xia W, Bennett DA, Foroud TM et al..  2022.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.. Alzheimers Dement. 18(11):2042-2054.
2018
Lee S, Zhou X, Gao Y, Vardarajan B, Reyes-Dumeyer D, Rajan KB, Wilson RS, Evans DA, Besser LM, Kukull WA et al..  2018.  Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly.. PLoS One. 13(11):e0206803.
Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL et al..  2018.  Sex-specific genetic predictors of Alzheimer's disease biomarkers.. Acta Neuropathol. 136(6):857-872.
2017
Desikan RS, Fan CChieh, Wang Y, Schork AJ, Cabral HJ, L Cupples A, Thompson WK, Besser L, Kukull WA, Holland D et al..  2017.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.. PLoS Med. 14(3):e1002258.
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, Carrell D, Cai Y, Fernandez MVictoria, Budde J et al..  2017.  Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.. Acta Neuropathol. 133(5):839-856.
Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R, Logue MW, Barnes LL, Bennett DA, Buxbaum JD et al..  2017.  Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.. Alzheimers Dement. 13(2):119-129.
2016
Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH et al..  2016.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
Hohman TJ, Cooke-Bailey JN, Reitz C, Jun G, Naj A, Beecham GW, Liu Z, Carney RM, Vance JM, Cuccaro ML et al..  2016.  Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.. Alzheimers Dement. 12(3):233-43.
Jakobsdottir J, van der Lee SJ, Bis JC, Chouraki V, Li-Kroeger D, Yamamoto S, Grove ML, Naj A, Vronskaya M, Salazar JL et al..  2016.  Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.. PLoS Genet. 12(10):e1006327.
2015
Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, Badarinarayan N, Morgan K, Passmore P, Holmes C et al..  2015.  Common polygenic variation enhances risk prediction for Alzheimer's disease.. Brain. 138(Pt 12):3673-84.
Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK, Holland D, Brewer JB, Chen C-H, Thompson WK et al..  2015.  Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.. Mol Psychiatry. 20(12):1588-95.
2013
Zhao W, Marchani EE, Cheung CYK, Steinbart EJ, Schellenberg GD, Bird TD, Wijsman EM.  2013.  Genome scan in familial late-onset Alzheimer's disease: a locus on chromosome 6 contributes to age-at-onset.. Am J Med Genet B Neuropsychiatr Genet. 162B(2):201-12.
Cruchaga C, Kauwe JSK, Harari O, Jin SChih, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D et al..  2013.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.. Neuron. 78(2):256-68.
2012
Jun G, Vardarajan BN, Buros J, Yu C-E, Hawk MV, Dombroski BA, Crane PK, Larson EB, Mayeux R, Haines JL et al..  2012.  Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.. Arch Neurol. 69(10):1270-9.
Schellenberg GD, Montine TJ.  2012.  The genetics and neuropathology of Alzheimer's disease.. Acta Neuropathol. 124(3):305-23.
Barral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, Graff-Radford N, Boeve BF, Sweet RA, Stern Y et al..  2012.  Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.. Neurology. 78(19):1464-71.
2011
Sherva R, Farrer LA.  2011.  Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.. Curr Psychiatry Rep. 13(2):138-46.
2010
Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A.  2010.  APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.. Sex Transm Infect. 86(3):202-6.
Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu C-E.  2010.  APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.. Am J Med Genet B Neuropsychiatr Genet. 153B(2):409-417.
Han M-R, Schellenberg GD, San Wang L-.  2010.  Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.. BMC Neurol. 10:90.
Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, M Fallin D, Friedland R et al..  2010.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.. Arch Neurol. 67(12):1473-84.